Agarwal Arjun's Form 4 filing
Oruka Therapeutics, Inc.ORKA · filed Sep 21, 2026
- Accession no.
- 0000907654-26-000102
- Filed
- Sep 21, 2026, 5:38 PM ET
- Trade date
- Sep 21, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $51.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Agarwal ArjunCIK 0002033974 | Officer (Senior Vice President, Finance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Common Stock | SSaleDisposed | −533 | $95.75 | −$51,034.75 | 14,219 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.